Martens AC
Martens AC
Associate Professor, Dept Hematology, VUMC (Free University)Medical Center Amsterdam Cell Biology
Geverifieerd e-mailadres voor vumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Dll1+ secretory progenitor cells revert to stem cells upon crypt damage
JH Van Es, T Sato, M Van De Wetering, A Lyubimova, ANY Nee, ...
Nature cell biology 14 (10), 1099-1104, 2012
6162012
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
MB Overdijk, S Verploegen, M Bögels, M van Egmond, JJL van Bueren, ...
MAbs 7 (2), 311-320, 2015
3642015
Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids
JML Roodhart, LGM Daenen, ECA Stigter, HJ Prins, J Gerrits, ...
Cancer cell 20 (3), 370-383, 2011
3172011
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo
R Siddappa, A Martens, J Doorn, A Leusink, C Olivo, R Licht, L Van Rijn, ...
Proceedings of the National Academy of Sciences 105 (20), 7281-7286, 2008
2262008
Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis
MB Rookmaaker, AM Smits, H Tolboom, K Van't Wout, AC Martens, ...
The American journal of pathology 163 (2), 553-562, 2003
2262003
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/-γc-/-double-mutant mice
RS van Rijn, ER Simonetti, A Hagenbeek, MCH Hogenes, RA de Weger, ...
Blood 102 (7), 2522-2531, 2003
2022003
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab
IS Nijhof, RWJ Groen, HM Lokhorst, B Van Kessel, AC Bloem, ...
Leukemia 29 (10), 2039-2049, 2015
1912015
Peyer's Patch M Cells Derived from Lgr5+ Stem Cells Require SpiB and Are Induced by RankL in Cultured “Miniguts”
W de Lau, P Kujala, K Schneeberger, S Middendorp, VSW Li, N Barker, ...
Molecular and cellular biology 32 (18), 3639-3647, 2012
1732012
Safety of retroviral gene marking with a truncated NGF receptor
C Bonini, M Grez, C Traversari, F Ciceri, S Marktel, G Ferrari, M Dinauer, ...
Nature medicine 9 (4), 367-369, 2003
1712003
Target antigen density governs the efficacy of anti–CD20-CD28-CD3 ζ chimeric antigen receptor–modified effector CD8+ T cells
K Watanabe, S Terakura, AC Martens, T Van Meerten, S Uchiyama, ...
The Journal of Immunology 194 (3), 911-920, 2015
1612015
Preclinical evidence for the therapeutic potential of CD38-targeted immuno-chemotherapy in multiple myeloma patients refractory to lenalidomide and bortezomib
IS Nijhof, RWJ Groen, WA Noort, B van Kessel, R de Jong-Korlaar, ...
Clinical cancer research 21 (12), 2802-2810, 2015
1342015
A rational strategy for reducing on-target off-tumor effects of CD38-chimeric antigen receptors by affinity optimization
E Drent, M Themeli, R Poels, R de Jong-Korlaar, H Yuan, J de Bruijn, ...
Molecular therapy 25 (8), 1946-1958, 2017
1322017
In vivo cytotoxicity of type I CD20 antibodies critically depends on Fc receptor ITAM signaling
S de Haij, JHM Jansen, P Boross, FJ Beurskens, JE Bakema, DL Bos, ...
Cancer research 70 (8), 3209-3217, 2010
1302010
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma
RWJ Groen, WA Noort, RA Raymakers, HJ Prins, L Aalders, FM Hofhuis, ...
Blood, The Journal of the American Society of Hematology 120 (3), e9-e16, 2012
1272012
Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model
WJC Rombouts, ACM Martens, RE Ploemacher
Leukemia 14 (5), 889-897, 2000
1082000
In vitro induction of alkaline phosphatase levels predicts in vivo bone forming capacity of human bone marrow stromal cells
HJ Prins, AK Braat, D Gawlitta, WJA Dhert, DA Egan, E Tijssen-Slump, ...
Stem cell research 12 (2), 428-440, 2014
1062014
Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies
H Rozemuller, HJ Prins, B Naaijkens, J Staal, HJ Bühring, AC Martens
Stem cells and development 19 (12), 1911-1921, 2010
1062010
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
E Drent, RWJ Groen, WA Noort, M Themeli, JJL van Bueren, PWHI Parren, ...
haematologica 101 (5), 616, 2016
1022016
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation
WA Noort, M Oerlemans, H Rozemuller, D Feyen, S Jaksani, D Stecher, ...
Journal of cellular and molecular medicine 16 (8), 1827-1839, 2012
1002012
Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells
STA Roord, W de Jager, L Boon, N Wulffraat, A Martens, B Prakken, ...
Blood, The Journal of the American Society of Hematology 111 (10), 5233-5241, 2008
972008
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20